Adjunctive Clindamycin Versus Linezolid for β-lactam Treated Patients With Invasive Group A Streptococcal Infections

Clinical trial NCT06126263 · UNKNOWN

Trial details

NCT number: NCT06126263
Sponsor: National Institutes of Health Clinical Center (CC)
Status: UNKNOWN
Study type: OBSERVATIONAL

Streptococcal Sepsis Invasive Group A Beta-Haemolytic Streptococcal Disease Necrotizing Soft Tissue Infection Infection, Bloodstream Infection, Bacterial Streptococcal Toxic Shock Syndrome

Start date: 2023-01-01
Primary completion: 2024-04-30
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.